Quest Diagnostics Incorporated
DGX
$168.36
$0.5050.30%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.58% | 9.38% | 6.70% | 2.60% | -1.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.58% | 9.38% | 6.70% | 2.60% | -1.50% |
| Cost of Revenue | 12.30% | 9.40% | 6.71% | 3.20% | -0.10% |
| Gross Profit | 13.15% | 9.34% | 6.68% | 1.42% | -4.22% |
| SG&A Expenses | 12.82% | 8.95% | 7.68% | -3.49% | -10.68% |
| Depreciation & Amortization | 31.25% | 23.42% | 17.59% | -2.50% | -6.67% |
| Other Operating Expenses | -- | 200.00% | 0.00% | 90.00% | 100.00% |
| Total Operating Expenses | 12.70% | 9.53% | 7.06% | 1.89% | -2.31% |
| Operating Income | 11.89% | 8.50% | 4.61% | 7.17% | 3.62% |
| Income Before Tax | 13.62% | 5.75% | 3.29% | 10.95% | 5.86% |
| Income Tax Expenses | 16.53% | 6.83% | 10.08% | 20.10% | 14.29% |
| Earnings from Continuing Operations | 12.81% | 5.45% | 1.43% | 8.67% | 3.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.00% | 3.77% | 7.41% | 12.50% | 21.88% |
| Net Income | 13.10% | 6.03% | 1.99% | 10.22% | 5.79% |
| EBIT | 11.89% | 8.50% | 4.61% | 7.17% | 3.62% |
| EBITDA | 13.90% | 10.23% | 6.50% | 6.52% | 3.27% |
| EPS Basic | 13.00% | 6.43% | 2.56% | 11.04% | 7.62% |
| Normalized Basic EPS | 7.76% | 3.95% | 1.92% | 8.48% | 7.28% |
| EPS Diluted | 13.90% | 7.63% | 3.81% | 10.73% | 6.92% |
| Normalized Diluted EPS | 7.54% | 3.97% | 2.15% | 9.18% | 7.71% |
| Average Basic Shares Outstanding | 0.00% | -0.45% | -0.67% | -0.67% | -1.55% |
| Average Diluted Shares Outstanding | 0.22% | -0.44% | -0.88% | -1.32% | -1.96% |
| Dividend Per Share | 6.16% | 5.90% | 5.63% | 6.09% | 6.57% |
| Payout Ratio | -0.06% | -0.01% | 0.03% | -0.04% | -0.01% |